🇺🇸 FDA

Company profile · Sponsor

ViiV

ViiV Healthcare B.V.

E1D9E58 · EMA pharma EU
Pipeline
3
Drugs
0
Patents
0

Quick answer

ViiV (E1D9E58) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E1D9E58
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (3)

Search pipeline →

  1. DTG + 3TC

    ViiV

    HIV Infections

    phase 3 small molecule completed

    1 trial

  2. Dolutegravir/abacavir/lamivudine FDC

    ViiV

    Infection, Human Immunodeficiency Virus

    phase 3 small molecule completed

    1 trial

  3. BMS-955176

    ViiV

    HIV Infections

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

What is ViiV?

ViiV (E1D9E58) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does ViiV sponsor?

We track 3 ClinicalTrials.gov-linked programs for ViiV, including DTG + 3TC and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does ViiV company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.